The George Pantziarka TP53 Trust The George Pantziarka TP53 Trust
  • Home
  • About Us
    • Meet The Team
    • Strategic Plan 2023
    • How We Started
    • George’s Story
    • Ten Years and Counting – looking back and looking forward
    • Contact
  • LFS / TP53
    • LFS Awareness
    • LFS UK 2024
    • LFS UK 2023
    • LFS UK 2022
    • LFS UK 2021
    • LFS UK 2019
    • LFS UK 2018
    • LFS UK 2017
    • LFS UK 2016
    • TP53 Testing
    • Mastectomy – Yes or No?
    • FAQ
  • Research
    • UK Study for Parents of Children with LFS
    • The MILI trial – reducing cancer risk with metformin
    • Towards a TP53 Registry
    • Interview with Min Lu
    • Interview with Galina Selivanova
    • Interview with Pan Pantziarka
  • Resources
    • LiNCR – Li Fraumeni Network for Clinicians and Researchers
    • Newsletter
    • UK Screening Recommendations
    • LFS Surveillance Protocol – Write to Your MP
    • Red Flags
    • Book recommendations
    • Alternatives to Radiotherapy
    • Blog
    • Useful Links
  • Active Trials
  • Home
  • About Us
    • Meet The Team
    • Strategic Plan 2023
    • How We Started
    • George’s Story
    • Ten Years and Counting – looking back and looking forward
    • Contact
  • LFS / TP53
    • LFS Awareness
    • LFS UK 2024
    • LFS UK 2023
    • LFS UK 2022
    • LFS UK 2021
    • LFS UK 2019
    • LFS UK 2018
    • LFS UK 2017
    • LFS UK 2016
    • TP53 Testing
    • Mastectomy – Yes or No?
    • FAQ
  • Research
    • UK Study for Parents of Children with LFS
    • The MILI trial – reducing cancer risk with metformin
    • Towards a TP53 Registry
    • Interview with Min Lu
    • Interview with Galina Selivanova
    • Interview with Pan Pantziarka
  • Resources
    • LiNCR – Li Fraumeni Network for Clinicians and Researchers
    • Newsletter
    • UK Screening Recommendations
    • LFS Surveillance Protocol – Write to Your MP
    • Red Flags
    • Book recommendations
    • Alternatives to Radiotherapy
    • Blog
    • Useful Links
  • Active Trials

Monthly Archives: March 2020

17 Mar 2020

Clinical Trial – Metformin in Li Fraumeni Syndrome

by PanP | 0

A clinical trial of the antidiabetic drug metformin is being developed for adults with Li Fraumeni Syndrome (LFS). This is the MILI trial – which we’ve discussed before. The trial aims to test whether metformin can reduce the incidence of … Read More

4 Mar 2020

Aspirin – protection against chemo?

by PanP | 0

Chemotherapy is hard on kids, as any parent of a child who has had cancer treatment can confirm. For parents of children with Li Fraumeni Syndrome (LFS) we try and not to think too much about what the long-term effects … Read More

aspirin, drug repurposing, research

Recent Posts

  • Newsletter #9
  • Newsletter #8
  • Germline p53 isoforms – causing familial cancer?
  • Newsletter #7
  • Why Is MILI Randomised?

Recent Comments

  • CC on How many people are there with LFS?
  • Vic on Funding for Whole-body MRI On The Way
  • Samantha Whyte on LFS Register for the UK
  • Tricia Walsh on Online Support Call – Maggie’s Survey
  • Pan on ON-HOLD – New Update Due Soon!

Please follow & like us

RSS
Follow by Email
Facebook
fb-share-icon

Archives

  • April 2025
  • January 2025
  • November 2024
  • August 2024
  • May 2024
  • April 2024
  • January 2024
  • October 2023
  • August 2023
  • July 2023
  • May 2023
  • August 2022
  • March 2022
  • February 2022
  • November 2021
  • February 2021
  • November 2020
  • October 2020
  • March 2020
  • December 2019
  • September 2017
  • December 2016
  • August 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015

Tags

aspirin colorectal cancer drug repurposing early diagnosis fundraising MILI probitocs repurposing research risk reduction screening web site
  • Privacy Policy and Disclaimer

© 2025 The George Pantziarka TP53 Trust | Registered Charity Number 1157167